DRUG
Bright Minds Biosciences Inc.NASDAQHealthcare$71.46+4.93%ClosedMarket Cap: $554.6M
As of 2026-04-06
Analyst Consensus
Consensus
Buy
Target (Consensus)
$136.50
Target (Median)
$136.50
Target Range
$126.00 - $147.00
Upside from current price: 91.0%
Rating Distribution
1 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-03-30 | BTIG | maintain | Buy | Buy |
| 2026-03-04 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-17 | BTIG | maintain | Buy | Buy |
| 2026-01-07 | BTIG | maintain | Buy | Buy |
| 2026-01-02 | Chardan Capital | maintain | Buy | Buy |
| 2025-12-30 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-09-15 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-05-21 | Chardan Capital | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Sep 30 | $-7.36 | $33.8M | 4 |
| Sat Sep 30 | $-9.37 | $36.3M | 5 |
| Sun Sep 30 | $-7.31 | $103.8M | 1 |
| Mon Sep 30 | $-4.76 | $105.7M | 1 |